ARG30315
Brain Injury IHC Marker Antibody Duo (GFAP, MMP9)
Publication10
Component
Cat No | Component Name | Host clonality | Reactivity | Application | Package |
---|---|---|---|---|---|
ARG22191 | anti-MMP9 antibody [SB15c] | Mouse mAb | Hu | ELISA, ICC/IF, IHC-P, WB | 50 μg |
ARG10122 | anti-GFAP antibody [GF5] | Mouse mAb | Hu, Ms, Rat | ELISA, ICC/IF, IHC-Fr, WB | 50 μg |
Overview
Product Description | Glial fibrillary acidic protein (GFAP) is the major intermediate filament protein in mature astrocytes, a main type of glial cells in the central nervous system (CNS). GFAP is augmented in astrogliosis, a pathophysiology associated with degenerative and infectious/inflammatory brain disorders. Matrix metalloproteinase 9 (MMP-9) is a member of metalloproteinases family. It cleaves ECM and cell surface receptors allowing for synaptic and circuit level reorganization. MMP-9 level is increased after traumatic brain injury and involved in the following excitotoxic neuronal loss. arigo's ARG30292 Brain Injury IHC Marker Antibody Duo (GFAP, MMP9) comprise two antibodies against GFAP and MMP9, the pathological hallmark of CNS lesions, and is excellent for histological analysis of brain injury. Related news: Astrocyte-to-neuron conversion for Parkinson's disease treatment |
---|---|
Target Name | Brain Injury IHC Marker |
Alternate Names | Brain Injury IHC Marker antibody; GFAP antibody; MMP9 antibody |
Properties
Storage Instruction | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
---|---|
Note | For laboratory research only, not for drug, diagnostic or other use. |
Specific References